Now that they have the single drug baseline it should be simple enough to a combo trial and compare results. Similarly for large number of cancers, which is how I understand our “all comers any cancer” trial. So any improvements are easily identifiable.
Industry news, page-1661
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.005(0.35%) |
Mkt cap ! $239.6M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.45 | $1.43 | $23.62K | 16.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 277 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 1105 | 3 |
View Market Depth
| Last trade - 12.21pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.44 |
Change
-0.005 ( 0.79 %) |
||||
| Open | High | Low | Volume | ||
| $1.43 | $1.45 | $1.43 | 2813 | ||
| Last updated 13.18pm 30/05/2024 ? | |||||
| RAC (ASX) Chart |